Karanth S, Lyson K, McCann S M
Department of Physiology, University of Texas Southwestern Medical Center, Dallas 75235-8873.
Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3383-7. doi: 10.1073/pnas.90.8.3383.
Stimulation of corticotropin-releasing factor (CRF) release from the hypothalamus by interleukin 2 (IL-2) was recently demonstrated. Cytokines induce nitric oxide synthase (NOS), an enzyme that converts L-arginine into L-citrulline and nitric oxide (NO). NO is believed to be responsible for the cytotoxic action of these agents. The constitutive form of NOS occurs in neurons in the central nervous system and NO appears to play a neurotransmitter role in cerebellar and hippocampal function. We explored the probability that IL-2 and synaptic transmitters might release CRF via NO. The effects of L-arginine, the substrate for NOS, and NG-monomethyl-L-arginine (NMMA), a competitive inhibitor of NOS, on IL-2-induced CRF release were studied using mediobasal hypothalami (MBHs) incubated in vitro in Krebs-Ringer bicarbonate buffer. L-Arginine did not alter basal and IL-2-induced CRF release after 30 min of incubation but significantly elevated both basal and IL-2-induced CRF release when MBHs were incubated 30 min longer, presumably because the endogenous substrate had been depleted after the initial 30-min incubation period. In 30-min incubations, both carbachol, an acetylcholineomimetic drug, and norepinephrine stimulated CRF release. There was an additive effect of incubation of the MBHs in the presence of carbachol (10(-7) M) and IL-2 (10(-13) M). On the other hand, coincubation of MBHs with norepinephrine (10(-6) M) and IL-2 (10(-13) M) did not produce any additive effect. Addition of NMMA, an inhibitor of NOS, at 1 or 3 x 10(-4) M completely suppressed IL-2-induced release of CRF as well as that caused by IL-2 plus carbachol. In contrast, the release of CRF induced by norepinephrine was not blocked by 3 x 10(-4) M NMMA. The data indicate that IL-2 can activate constitutive NOS leading to increased NO release, which activates CRF release. It appears that NO is also involved in the release of CRF induced by carbachol but not by norepinephrine.
最近有研究表明,白细胞介素2(IL - 2)可刺激下丘脑促肾上腺皮质激素释放因子(CRF)的释放。细胞因子可诱导一氧化氮合酶(NOS)的产生,该酶能将L - 精氨酸转化为L - 瓜氨酸和一氧化氮(NO)。人们认为NO是这些物质细胞毒性作用的原因。NOS的组成型形式存在于中枢神经系统的神经元中,且NO似乎在小脑和海马功能中发挥神经递质的作用。我们探究了IL - 2和突触递质是否可能通过NO释放CRF。使用在含有碳酸氢盐的克雷布斯 - 林格缓冲液中进行体外孵育的下丘脑中间基底部(MBH),研究了NOS的底物L - 精氨酸和NOS的竞争性抑制剂NG - 单甲基 - L - 精氨酸(NMMA)对IL - 2诱导的CRF释放的影响。孵育30分钟后,L - 精氨酸并未改变基础状态以及IL - 2诱导的CRF释放,但当MBH再额外孵育30分钟时,基础状态以及IL - 2诱导的CRF释放均显著升高,推测是因为在最初30分钟的孵育期后内源性底物已被耗尽。在30分钟的孵育实验中,拟胆碱药卡巴胆碱和去甲肾上腺素均刺激了CRF的释放。在存在卡巴胆碱(10⁻⁷ M)和IL - 2(10⁻¹³ M)的情况下孵育MBH有相加效应。另一方面,将MBH与去甲肾上腺素(10⁻⁶ M)和IL - 2(10⁻¹³ M)共同孵育未产生任何相加效应。添加1×10⁻⁴ M或3×10⁻⁴ M的NOS抑制剂NMMA可完全抑制IL - 2诱导的CRF释放以及IL - 2加卡巴胆碱所引起的CRF释放。相比之下,3×10⁻⁴ M的NMMA并未阻断去甲肾上腺素诱导的CRF释放。数据表明,IL - 2可激活组成型NOS,导致NO释放增加,进而激活CRF释放。似乎NO也参与了卡巴胆碱诱导的CRF释放,但未参与去甲肾上腺素诱导的CRF释放。